Related Experiment Video

Updated: Aug 24, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Ophthalmologic monitoring for antimalarial toxicity

Petros P Sfikakis, Myron Mavrikakis

    The Journal of Rheumatology
    |May 5, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
    08:31

    Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

    Published on: October 11, 2019

    Related Experiment Videos

    Last Updated: Aug 24, 2026

    Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
    10:10

    Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

    Published on: February 15, 2022

    Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
    08:31

    Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

    Published on: October 11, 2019

    Related Concept Videos

    Open Angle Glaucoma: Treatment01:27

    Open Angle Glaucoma: Treatment

    In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
    Drugs such as carbonic anhydrase inhibitors, α2- and...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

    Articles linked to this work by shared authors, journal, and citation graph.

    Development and implementation of the international AIDA network spondylarthritis registry.

    Frontiers in medicine·2025

    Sustainable, planetary healthy dietary patterns are associated with lower 20-year incidence of cardiovascular disease: the ATTICA study (2002-2022).

    European journal of clinical nutrition·2025

    Very long-term remission in behcet's disease following withdrawal of anti-TNF treatment exceeds relapses: a reappraisal of an outcome study.

    Rheumatology international·2025

    Exploring the Path Between Life-Course Trajectories of Physical Activity Levels and Cardiometabolic Disease Incidence: Insights From the ATTICA Cohort Study (2002-2022).

    Journal of physical activity & health·2025

    Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002-2022).

    European journal of internal medicine·2025

    Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry.

    Seminars in arthritis and rheumatism·2025

    Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

    The Journal of rheumatology·2026

    Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

    The Journal of rheumatology·2026

    Remission rates of patients with axial spondyloarthritis in a tertiary care center.

    The Journal of rheumatology·2026

    Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

    The Journal of rheumatology·2026

    Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

    The Journal of rheumatology·2026

    Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

    The Journal of rheumatology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us